Cancer Immunology, Immunotherapy

Published by: Springer  

Groups

  1. Adult Leukemia (1)
  2. Advanced Practice Providers (1)
  3. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  4. Center for Hematologic Malignancies (1)
  5. Department of Medicine (1)
  6. GSK Faculty (1)
  7. Hematologic Malignancies Research (1)
  8. Hematologic Malignancies, Division of (1)
  9. Melanoma and Immunotherapeutics Service (1)
  10. Molecular Pharmacology and Chemistry Program Faculty (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.

Cancer Immunology, Immunotherapy – authorized name for:

Name ISSN / ISBN Publisher
Cancer Immunology and Immunotherapy 978-3-642-14136-2 Springer Verlag
Cancer Immunology Immunotherapy 0340-7004 Springer
Cancer Immunology Immunotherapy 0340-7004 Unknown
Cancer Immunology Immunotherapy 0340-7004 Springer
Cancer Immunology Immunotherapy 0340-7004 Springer
Cancer Immunology Immunotherapy 0340-7004 Springer Verlag
Cancer Immunology Immunotherapy 03407004 Springer Verlag
Cancer Immunology Immunotherapy 03407004 Unknown
Cancer Immunology Immunotherapy 0340-7004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 03407004 2022, The Author(s), Under Exclusive Licence To Springer Verlag Gmbh Germany, Part of Springer Nature
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 03407004 2018, Springer Verlag Gmbh Germany, Part of Springer Nature
Cancer Immunology, Immunotherapy 03407004 2019, The Author(s)
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 03407004 The Author(s)
Cancer Immunology, Immunotherapy 03407004 2022, The Author(s)
Cancer Immunology, Immunotherapy 03407004 2023, The Author(s)
Cancer Immunology, Immunotherapy 03407004 2023, The Author(s), Under Exclusive Licence To Springer Verlag Gmbh Germany, Part of Springer Nature
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 03407004 Springer Verlag Berlin Heidelberg
Cancer Immunology, Immunotherapy 03407004 Springer Verlag Berlin Heidelberg
Cancer Immunology, Immunotherapy 03407004 The Author(s) 2024
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 03407004 Springer Verlag
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 0340-7004 Springer
Cancer Immunology, Immunotherapy 03407004 Unknown
Cancer Immunology, Immunotherapy 03407004 Us Government